News und Analysen

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels.

However, the rising popularity of GLP-1 drugs, which are

Genomic sequencing specialist Illumina (NASDAQ: ILMN) was something of a victim in the U.S.-China trade spat on Tuesday. The government of the sprawling Asian nation placed the U.S. company on a

Image source: The Motley Fool.

Centene (NYSE: CNC)Q4 2024 Earnings CallFeb 04, 2025, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors last year due to

The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the performance of many top stocks reflects this reality. However, a share price

I'm loading my retirement account with dividend stocks. The thesis is simple: Dividend stocks have historically outperformed non-dividend payers by more than 2-to-1 over the past 50 years and have

ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst

Shares of Cigna (NYSE: CI) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% earlier in the day. The leg down comes as the S&P 500 gained 0.2% and the

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q4 2024 Earnings CallJan 30, 2025, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

It takes money to make money. However, you don't need a lot to get started. Many top-notch dividend stocks have share prices below $100 right now.

That's worth noting, given the powerful returns

CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry. In addition to its pharmacy retail operations, the company has a pharmacy

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even more than the dividend yield. Corporations with high yields may look

If you're a dividend investor, I can understand why -- because dividend-paying stocks offer a triple upside: As long as the underlying company is healthy and growing, its stock price will likely